Abstract Background and Aims The COVID‐19 pandemic and the infection of numerous
individuals from diverse societies have emerged as major global challenges. Given the …

Objective To identify markers associated with in-hospital death in patients with coronavirus
disease 2019 (COVID-19)–associated pneumonia. Patients and Methods A retrospective …

Aim: In this study, it was aimed whether biochemical parameters, vital signs and neutrophil-
lymphocyte ratio (NLR) values could be used in determining the indication for intensive care …

Introduction: COVID-19 is mainly a respiratory illness, causing hypoxemia in the majority of
those been infected. In our study, we aimed to correlate the biochemical markers with …

Many COVID-19 patients have very low arterial partial oxigen tension while severe dyspnoe
does not develop. Pulse oxymetry indicates only moderate reduction of arterial O2 saturation …

Background Acute hypoxic respiratory failure (AHRF) is a hallmark of severe COVID-19
pneumonia and often requires supplementary oxygen therapy. Critically ill COVID-19 …

Abstract Objective: Early identification of Coronavirus disease 2019 (COVID-19) patients at
high mortality risk can improve patient care and prevent deaths. To identify prognostic …

Background: Coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China in
December 2019. It is caused by SARS-CoV-2, a beta coronavirus. In this study, we assessed …

Aims: The aim of this study was to determine the mortality risk factors of hospitalized
moderate-to-severe coronavirus disease 2019 (COVID-19) patients in Tehran. Materials and …

Background: Early identification of patients with poor prognosis may facilitate the provision
of proper supportive treatment in advance and reduce mortality due to Coronavirus Disease …